Therefore, we suspect that the significant elevation of p21 observed in the lung cancer cells treated with SAHA might have led to a decrease in the AKT levels, which in turn could have contributed to the decrease in PD-L1 expression. The gene discussed is AKT1; the disease is lung carcinoma.